Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery
NCT04922333Phase 3Recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Mar 2023
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of risedronate in osteoporosis, sponsored by Wake Forest University Health Sciences. Started Mar 2023; status: recruiting.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT04922333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04922333.